What's new

Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Authorised

Apr 9, 2025 - 13:19
 0
Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

Hesai secures new order for 200,000 LiDARs from Leapmotor

Next Article

Deputy Secretary General Radmila Shekerinska meets with CEOs of the German Chemi...

Related Posts

EMEA-001716-PIP07-22

EMEA-001716-PIP07-22

Feb 14, 2025  0

PSUSA/00002087/202407

PSUSA/00002087/202407

Mar 19, 2025  0

Herbal medicinal product: Salicis cortex, Salix [various species including S. purpurea L.; S. daphnoides Vill.; S. fragilis L.], F: Assessment finalised

Herbal medicinal product: Salicis cortex, Salix [variou...

Apr 1, 2025  0